RT Book, Section
A1 Papadakis, Maxine A.
A1 McPhee, Stephen J.
A1 Rabow, Michael W.
SR Print(0)
ID 1175351101
T1 Mycotic Infections
T2 Current Medical Diagnosis & Treatment 2021
YR 2021
FD 2021
PB McGraw-Hill Education
PP New York, NY
SN 9781260469868
LK accessmedicine.mhmedical.com/content.aspx?aid=1175351101
RD 2021/03/01
AB For  Candida  glabrata  resistant  to  azoles  and  echinocandins,  lipid  formulation  amphotericin  B  (3–5  mg/kg  intravenously  daily)  may  be  used.